<DOC>
	<DOCNO>NCT02729623</DOCNO>
	<brief_summary>Growing evidence support use inhaled cannabis neuropathic pain ; lack standard inhaled dosing hold major obstacle cannabis become pharmacological treatment neuropathic pain . The objective study explore pharmacokinetics , safety , tolerability , ease use portable metered-dose inhaler , ( i.e . CannaHALER ) cannabis cohort 12 healthy volunteer . In single escalate dose methodology , open-label study , patient inhale single 10 ± 0.1 mg / 15 ± 0.1 mg / 20 ± 0.1 mg / 25 ± 0.1 mg dose cannabis use Kite Systems cannaHALER cannabis Inhaler device . Blood sample take baseline 30 minute . Adverse event monitor follow inhalation .</brief_summary>
	<brief_title>The Pharmacokinetics , Safety , Ease Use Portable Metered-Dose Cannabis Inhaler</brief_title>
	<detailed_description />
	<criteria>age 3070 year ; healthy applicable , negative pregnancy test ( β human chorionic gonadotropin pregnancy test ) . significant cardiac pulmonary disease , history psychotic anxiety disorder , pregnancy , pregnancy attempt breastfeeding , presence neuropathic nonneuropathic pain , low blood pressure , 90 mm Hg ( systolic ) Diabetes diagnosed , first degree family history psychotic anxiety disorder , history drug addiction , history drug misuse , use follow drug : Rifampicin , Rifabutin , Carbamazepine , Phenobarbital , Primidone , use follow plant : Hypericum perforatum , troglitazone , Alcohol consumption 12 hour study , abnormal parameter Heart Rate 100 BPM , Blood pressure , 90 mm Hg ( systolic ) , Saturation 91 percent , Cannabis use 12 hour study , health condition could affect alter experiment result , Volunteer legal guardian . Chronic use drug , age less 30 70 , health condition could affect outcome trial constitutes risk factor participation trial . The experiment include special population pregnant woman , child without judgement .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>